Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -108,025 | -78,726 | -87,968 | -144,250 | -8,347 |
| Depreciation Amortization | 69,821 | 75,461 | 75,459 | 72,269 | 56,093 |
| Accounts receivable | -6,178 | -19,313 | -11,516 | -7,581 | -4,691 |
| Other Working Capital | -32,095 | -32,630 | -25,493 | -31,701 | -4,600 |
| Other Operating Activity | 81,707 | 62,231 | 47,565 | 45,270 | -65,178 |
| Operating Cash Flow | $5,230 | $7,023 | $-1,953 | $-65,993 | $-26,723 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,060 | 53,916 | 105,459 | 19,310 | -133,821 |
| PPE Investments | -24,942 | -41,061 | -28,752 | -18,793 | -64,142 |
| Net Acquisitions | -6,454 | N/A | N/A | N/A | -419,404 |
| Purchase Of Investment | -1,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -15,000 |
| Investing Cash Flow | $-12,336 | $12,855 | $76,707 | $517 | $-632,367 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 334,410 |
| Debt Repayment | -201,250 | N/A | -70 | -758 | -3,047 |
| Common Stock Issued | 962 | 4,646 | 4,624 | 12,587 | 423,213 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -29,291 |
| Financing Cash Flow | $-200,288 | $4,646 | $4,554 | $11,829 | $725,285 |
| Beginning Cash Position | 367,012 | 342,488 | 263,180 | 316,827 | 250,632 |
| End Cash Position | 159,618 | 367,012 | 342,488 | 263,180 | 316,827 |
| Net Cash Flow | $-207,394 | $24,524 | $79,308 | $-53,647 | $66,195 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,230 | 7,023 | -1,953 | -65,993 | -26,723 |
| Capital Expenditure | -27,008 | -41,061 | -28,752 | -30,891 | -64,142 |
| Free Cash Flow | -21,778 | -34,038 | -30,705 | -96,884 | -90,865 |